TAMPA, Fla.--(December 06, 2011) – Oragenics, Inc. (OTCQB:ORNI), a Florida-based nutraceutical company focused on oral care probiotics, announced today the appointment of Dr. Martin Handfield as Vice President of Research and Dr. Robert Zahradnik as Vice President of Operations. Both gentlemen have a long-standing relationship with Oragenics.
Dr. Handfield joined Oragenics in 2009 as the Director of Research and Development. He has previously conducted research alongside Oragenics founder, Dr. Jeff Hillman.
Dr. Zahradnik, one of the co-founders of Oragenics has served in several senior capacities for the Company. He has held a variety of senior level positions in the health care arena and is currently working on expanding Oragenics' patented blend of probiotics, ProBiora3®, for oral care.
Dr. John N. Bonfiglio, Ph.D., CEO of Oragenics stated, “The talent Dr. Handfield and Dr. Zahradnik provide has helped Oragenics advance at an accelerated pace. Given the goals for 2012 to further enhance ProBiora3® as an active ingredient and advancing our Evora® product lines to the consumer market, the knowledge, expertise in probiotics, and ongoing dedication to Oragenics of these two seasoned professionals will continue to be significant.”
“As Oragenics continues focusing on offering world-class probiotic-based oral care solutions, the new roles each gentlemen play will be integral to our future growth plan,” Bonfiglio concluded.
About Oragenics, Inc.
Oragenics is a leading nutraceutical company focused on oral care probiotics for humans and companion pets. The Company's proprietary products Evora® and ProBiora3® are currently sold in over 20 countries. In addition, Oragenics has a robust pipeline of therapeutic products targeting infectious disease.